Liên Minh Châu Âu -
Tiếng Estonia -
EMA (European Medicines Agency)
ellaone
laboratoire hra pharma - ulipristaal - kontraceptsioon, postkoital - suguhormoonid ja genitaalsüsteemi, , hädaabi rasestumisvastased vahendid - hädaabi kontratseptsioon 120 tundi (5 päeva) rasestumisvastaseid vahendeid või kaitsmata seksuaalvahekorras.
Liên Minh Châu Âu -
Tiếng Estonia -
EMA (European Medicines Agency)
exalief
bial - portela ca, s.a. - eslikarbasepiinatsetaat - epilepsia - antiepileptics, - exalief on näidustatud täiendava ravina täiskasvanutel, kellel esinevad osalised epilepsiahoogid koos sekundaarse generaliseerumisega või ilma.
Liên Minh Châu Âu -
Tiếng Estonia -
EMA (European Medicines Agency)
suprelorin
virbac s.a. - desloreliinatsetaat - hüpofüüsi ja hüpotaalamuse hormoonid ja analoogid - dogs; ferrets - ajutise viljatuse tekitamiseks tervetel, tervedel, seksuaalselt küpsed isastel koertel ja tuhkrutel.
Liên Minh Châu Âu -
Tiếng Estonia -
EMA (European Medicines Agency)
ypozane
virbac s.a. - osateroonatsetaat - uroloogilised ravimid - koerad - healoomulise eesnäärme hüpertroofia (bph) ravi isastel koertel.
Liên Minh Châu Âu -
Tiếng Estonia -
EMA (European Medicines Agency)
ioa
n.v. organon - nomegestrol atsetaat, östradiooli - kontraceptsioon - suguhormoonid ja genitaalsüsteemi, - suukaudne kontratseptsioon.
Liên Minh Châu Âu -
Tiếng Estonia -
EMA (European Medicines Agency)
zebinix
bial - portela & ca, s.a. - eslikarbasepiinatsetaat - epilepsia - antiepileptics, - zebinix on näidustatud lisaravina täiskasvanutel, noorukitel ja lastel üle 6 aasta, koos sekundaarse generaliseerumisega või ilma partsiaalsete hoogude.
Liên Minh Châu Âu -
Tiếng Estonia -
EMA (European Medicines Agency)
abiraterone mylan
mylan ireland limited - abirateroonatsetaat - eesnäärmevähk - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
Liên Minh Châu Âu -
Tiếng Estonia -
EMA (European Medicines Agency)
abiraterone krka
krka, d.d., novo mesto - abirateroonatsetaat - eesnäärmevähk - endokriinset ravi - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.